Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Ozempic is self-administered with an injection pen Credit: Carolina Rudah “People are living another 10 to 15 years and they want to look what they feel like, not what they may physically look ...
The Samsung Galaxy S25 Ultra S Pen no longer supports Bluetooth connectivity, removing features like Air Actions. Samsung says the change was made due to low user engagement and suggests using ...
Samsung has removed Bluetooth functionality from the Galaxy S25 Ultra’s S Pen. Without Bluetooth, the S Pen does not support Air Actions and can no longer be used as a remote. The Galaxy S25 ...
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback